SUBSCRIBE
SUBSCRIBE
Biotech Bay

Blood Test Matches Biopsy as Heart Rejection Monitor, Stanford University Study

April 22, 2010 | 
1 min read

MedPage Today -- Gene-expression profiling could safely replace routine biopsies for monitoring rejection in low-risk heart transplant patients, according to a randomized trial.

MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: 3D image of a KRAS oncogene
Business
BridgeBio Spins Out Oncology Company with $200M in Financing
May 2, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Bristol Myers Squibb office in California
Biotech Bay
BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement
April 22, 2024
 · 
2 min read
 · 
Tyler Patchen